Sutro Biopharma, Inc.

Direct answer

Sutro Biopharma, Inc. is publicly traded on NASDAQ under the ticker STRO.

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients...

Can you invest in Sutro Biopharma, Inc.?

Yes. Sutro Biopharma, Inc. is publicly traded on NASDAQ under the ticker STRO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Sutro Biopharma, Inc.

Detailed equity research is provided by MarketSnap.